![Combined burden and functional impact tests for cancer driver discovery using DriverPower | Nature Communications Combined burden and functional impact tests for cancer driver discovery using DriverPower | Nature Communications](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-019-13929-1/MediaObjects/41467_2019_13929_Fig1_HTML.png)
Combined burden and functional impact tests for cancer driver discovery using DriverPower | Nature Communications
Guardant Health Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Revenue Outlook for Full Year 2021 2020
![Microorganisms | Free Full-Text | Systematic Review of Plasmid AmpC Type Resistances in Escherichia coli and Klebsiella pneumoniae and Preliminary Proposal of a Simplified Screening Method for ampC | HTML Microorganisms | Free Full-Text | Systematic Review of Plasmid AmpC Type Resistances in Escherichia coli and Klebsiella pneumoniae and Preliminary Proposal of a Simplified Screening Method for ampC | HTML](https://www.mdpi.com/microorganisms/microorganisms-10-00611/article_deploy/html/images/microorganisms-10-00611-g001.png)
Microorganisms | Free Full-Text | Systematic Review of Plasmid AmpC Type Resistances in Escherichia coli and Klebsiella pneumoniae and Preliminary Proposal of a Simplified Screening Method for ampC | HTML
![Illumina sues Guardant Health, claiming founders stole cancer testing trade secrets | Fierce Biotech Illumina sues Guardant Health, claiming founders stole cancer testing trade secrets | Fierce Biotech](https://qtxasset.com/quartz/qcloud5/media/image/fiercebiotech/1631883279/blood-group-2781421_1280.jpg/blood-group-2781421_1280.jpg?VersionId=E27ndIb7GKnuA2bv.Yi4Ls3WABphSnip)